Merck & Co Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Merck & Co Inc
TickerMRK
CIK #0000310158
CUSIP58933Y105
SectorLife Sciences - Pharmaceutical Preparations
AddressOne Merck Drive PO Box 100, Whitehouse Station, NJ 08889-0100
Source [EDGAR]
CIK Filing 2011 - 2025
[0000310158] 10-K
[0000310158] 10-Q
[0000310158] 13F-HR
[0000310158] 3
[0000310158] 4
[0000310158] 5
[0000310158] 8-K
[0000310158] SC 13D
[0000310158] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Merck & Co Inc Personalis Inc [2024-12-23] 0.0
Merck & Co Inc Evaxion Biotech A/S [2024-01-23] 11.4
Merck & Co Inc 4D Pharma PLC [2022-02-02] 0.0
Merck & Co Inc Pandion Therapeutics Inc [2021-03-04] 39.99
Merck & Co Inc Yumanity Therapeutics Inc [2021-01-04] 0.0
Merck & Co Inc Arqule Inc [2019-12-16] 12.6
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09] 19.9
Merck & Co Inc Alector Inc [2019-02-14] 5.1
Merck & Co Inc Sutro Biopharma Inc [2018-10-04] 11.9
Merck & Co Inc Menlo Therapeutics Inc [2018-02-14] 5.41
Merck & Co Inc Spero Therapeutics Inc [2017-11-15] 6.5
Merck & Co Inc KalVista Pharmaceuticals Inc [2017-10-16] 0.9
Capital World Investors Merck & Co Inc [2017-02-13] 5.1
Merck & Co Inc BeiGene Ltd [2016-02-12] 7.4
Vanguard Group Inc Merck & Co Inc [2015-02-11] 5.46
Merck & Co Inc Idenix Pharmaceuticals Inc [2014-06-13] 14.9
Wellington Management Co LLP Merck & Co Inc [2014-02-14] 5.27
Form 3/4/5 Filer 2011 - 2025
Merck & Co., Inc.
Guindo Chirfi
Williams David Michael
Coe Mary Ellen
Glocer Thomas H
Seidman Christine E
Craig Pamela J.
Lavizzo-Mourey RISA J
Karsanbhai Surendralal Lanca
Baker Douglas M Jr
Warden Kathy J
Thulin Inge G
Russo Patricia F
Rothman Paul
Mayo Stephen
Smart Dalton E. III
Larson Betty D
Romanelli Joseph
Oosthuizen Johannes Jacobus
Chattopadhyay Sanat
DeLuca Richard R.
Davis Robert M
Li Dean Y
Zachary Jennifer
Downing Cristal N
Litchfield Caroline
Merck Sharp & Dohme LLC
Personalis, Inc.
Klobuchar Michael A
Wendell Peter C
Harpoon Therapeutics, Inc.
Mizell Steven
LeCointe-Cephas Lisa
Karachun Rita A
Frazier Kenneth C
Garay Arpa
Gerberding Julie L.
Clyburn Frank
Organon & Co.
Brun Leslie A
Pandion Therapeutics, Inc.
Nally Michael
Fleming Michael
Cech Thomas R
Weeks Wendell P
Perlmutter Roger M
Lazarus Rochelle B
Merck Sharp & Dohme Corp.
Arqule Inc
Scholefield James H
NGM Biopharmaceuticals Inc
Noseworthy John H
Schechter Adam H
Watson Ashley
Sutro Biopharma Inc
Thompson Craig B.
Graddick Weir Mirian M
Holston Michael J
Opgen Inc
Merck Global Health Innovation Fund, LLC
VYNE Therapeutics Inc.
Represas Carlos E
Kidder C Robert
Ambrose Adele D
Golestani Clark
Rosenblatt Michael
Harrison William B Jr
Deese Willie A
BeOne Medicines Ltd.
Merck Sharp & Dohme Research GmbH
Kuhlik Bruce N
Heller Bridgette P
Canan John
Kellogg Peter N
Do Cuong V
Kim Peter S
Bowles Richard S III
Scalet J Chris
Tatlock Anne M
Kelley Willam N
Goldstone Steven F
Kohan Raul E
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2025-06-30] SOLE 0 240,321,092
BlackRock, Inc. [2025-06-30] SOLE 196,704,938 218,340,832
State Street Corp [2025-06-30] DFND 66,570,117 118,493,864
Wellington Management Group LLP [2025-06-30] DFND 0 76,856,492
Geode Capital Management LLC [2025-06-30] DFND 58,896,493 58,952,681
Charles Schwab Investment Management Inc [2025-06-30] SOLE 53,611,498 53,699,088
Morgan Stanley [2025-06-30] DFND 21,677,371 44,200,694
Norges Bank [2025-06-30] SOLE 36,111,289 36,111,289
Bank of America Corp /DE/ [2025-06-30] DFND 7,516,905 32,710,434
FMR LLC [2025-06-30] DFND 21,508,479 31,566,125
JPMorgan Chase & Co [2025-06-30] DFND 25,576,647 31,344,592
Northern Trust Corp [2025-06-30] DFND 27,282,406 27,795,508
Franklin Resources Inc [2025-06-30] DFND 26,848,567 27,028,765
Fisher Asset Management LLC [2025-06-30] DFND 21,892,163 25,013,697
Bank of New York Mellon Corp [2025-06-30] DFND 17,592,385 21,232,329
Legal & General Group Plc [2025-06-30] DFND 17,703,221 19,503,045
Arrowstreet Capital Limited Partnership [2025-06-30] DFND 16,231,665 19,456,096
Goldman Sachs Group Inc [2025-06-30] DFND 17,538,580 18,925,853
UBS Group AG [2025-06-30] DFND 7,958,257 18,325,084
Invesco Ltd. [2025-06-30] DFND 0 17,023,170
Deutsche Bank AG [2025-06-30] DFND 9,053,104 16,815,302
Amundi [2025-06-30] DFND 16,375,026 16,532,657
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] DFND 7,038,216 13,245,588
Ameriprise Financial Inc [2025-06-30] DFND 0 13,198,450
Susquehanna International Group LLP [2025-06-30] OTR 1,899,857 12,851,057
Vanguard Group Inc [2025-06-30] DFND 8,592 12,593,334
Royal Bank of Canada [2025-06-30] DFND 11,803,502 12,420,999
Wells Fargo & Company/MN [2025-06-30] DFND 2,632,092 11,528,888
D. E. Shaw & Co., Inc. [2025-06-30] DFND 11,254,187 11,483,889
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 7,767,028 10,962,726
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com